Milestone Pharmaceuticals (MIST) Cash & Equivalents (2018 - 2026)
Milestone Pharmaceuticals' Cash & Equivalents came in at $169.73 million for Q2 2026, up 299.4% from $42.5 million a year earlier and up 138.0% from the prior quarter.
Powered by 
Analysis
Milestone Pharmaceuticals (MIST) Cash & Equivalents (2018 - 2026) Analysis & Trends
At the end of FY2025, Milestone Pharmaceuticals' Cash & Equivalents was $73.05 million, up 188.6% from FY2024.
- Cash & Equivalents has increased in each of the last three years, with a five-year compound annual growth rate of 0.2% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $25.31 million in FY2024 (+84.0%), $13.76 million in FY2023 (+80.2%), $7.64 million in FY2022 (-93.3%) and $114.14 million in FY2021 (+57.8%).
- The Q2 2026 figure represents the highest quarterly Cash & Equivalents in data going back to Q4 2018.
- Year-over-year, Cash & Equivalents has increased for eight consecutive quarters, with growth averaging 186.2% over the last eight quarters.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q1 2025 (growth of 345.0%), and the weakest in Q4 2022 (a decline of 93.3%).
- Business Quant data shows MIST's Cash & Equivalents at $71.32 million (Q1 2026), $73.05 million (Q4 2025) and $46.69 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Milestone Pharmaceuticals | 87.15 Mn | -83.45 Mn | - | 169.73 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 169.73 Mn |
| Mar 31, 2026 | 71.32 Mn |
| Dec 31, 2025 | 73.05 Mn |
| Sep 30, 2025 | 46.69 Mn |
| Jun 30, 2025 | 42.50 Mn |
| Mar 31, 2025 | 45.09 Mn |
| Dec 31, 2024 | 25.31 Mn |
| Sep 30, 2024 | 12.80 Mn |
| Jun 30, 2024 | 13.26 Mn |
| Mar 31, 2024 | 10.13 Mn |
| Dec 31, 2023 | 13.76 Mn |
| Sep 30, 2023 | 9.88 Mn |
| Jun 30, 2023 | 32.59 Mn |
| Mar 31, 2023 | 73.95 Mn |
| Dec 31, 2022 | 7.64 Mn |
| Sep 30, 2022 | 37.29 Mn |
| Jun 30, 2022 | 63.24 Mn |
| Mar 31, 2022 | 92.24 Mn |
| Dec 31, 2021 | 114.14 Mn |
| Sep 30, 2021 | 111.43 Mn |
API Access
Milestone Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=MIST&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "MIST", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=MIST&period=max&api_key=YOUR_API_KEY");
const data = await res.json();